Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Short Interest Down 24.1% in February

Retrieved on: 2021-03-06 08:58:03

Tags for this article:

Click the tags to see associated articles and topics

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Short Interest Down 24.1% in February. View article details on hiswai:

Excerpt

Morgan Stanley boosted their target price on Y-mAbs Therapeutics from $42.00 to $45.00 and gave the stock an "equal weight" rating in a report on ...

Article found on: www.marketbeat.com